Angiogenic therapy for muscular dystrophy

Grant Project Details:

Atsushi Asakura, PhD
University of Minnesota | Minneapolis, MN
In Process
Explore all RMM grants awarded since inception

Grant timeline: proposal, updates, reports

Grant Location

University of Minnesota
Minneapolis, MN 55414

Grant Description

Duchenne Muscular Dystrophy (DMD) is caused by mutations in the dystrophin gene, which normally functions to maintain muscle membrane integrity and prevent contraction‐induced damage. It may be possible to reduce muscle fiber damage by using pro‐angiogenic factors or endothelial progenitor cells to increase muscle perfusion and observe the resultant effects on the muscular dystrophy phenotype. We predict that these pro‐angiogenic factors and endothelial progenitor cells will assist in development of new therapies for DMD via increased vascular density in blood‐starved dystrophic muscles

Grant Awardee Biography

image of Atsushi Asakura, PhD